targeted synergy

The targeted synergy programme uses drug molecules that deliver two synergistic therapeutic activities to solid tumours; a genotoxic moiety plus an inhibitor of key DNA repair enzymes while remaining inherently safe to normal tissues. This programme is supported by the Seeding Drug Discovery Initiative from the Wellcome Trust